Characterization of High-Risk HIV-1 Seronegative Hemophiliacs

By Salkowitz J.R.   Purvis S.F.   Meyerson H.   Zimmerman P.   O'Brien T.R.   Aledort L.   Eyster M.E.   Hilgartner M.   Kessler C.   Konkle B.A.   White G.C.   Goedert J.J.   Lederman M.M.  

Clinical Immunology, Vol. 98, Iss. 2, 2001-02 ,pp. : 200-211

Academic Press

Access to resources Recommend Favorite

CD4⁺ T-Lymphocyte Nadir and the Effect of Highly Active Antiretroviral Therapy on Phenotypic and Functional Immune Restoration in HIV-1 Infection

By Lange C.G.   Valdez H.   Medvik K.   Asaad R.   Lederman M.M.  

Clinical Immunology, Vol. 102, Iss. 2, 2002-02 ,pp. : 154-161

Academic Press

Access to resources Recommend Favorite

Low-Dose IL-2 Reduces Lymphocyte Apoptosis and Increases Naive CD4 Cells in HIV-1 Patients Treated with HAART

By Pandolfi F.   Pierdominici M.   Marziali M.   Livia Bernardi M.   Antonelli G.   Galati V.   D'Offizi G.   Aiuti F.  

Clinical Immunology, Vol. 94, Iss. 3, 2000-03 ,pp. : 153-159

Academic Press

Access to resources Recommend Favorite

Antithrombin III inhibits lymphocyte proliferation, immunoglobulin production and mRNA expression of lymphocyte growth factors (IL-2, -IFN and IL-4) in vitro

By Zuo X.-J.   Nicolaidou E.   Okada Y.   Toyoda M.   Jordan S.C.  

Transplant Immunology, Vol. 9, Iss. 1, 2001-10 ,pp. : 1-6

Elsevier

Access to resources Recommend Favorite

Lower CD4+ T Lymphocyte Nadirs May Indicate Limited Immune Reconstitution in HIV-1 Infected Individuals on Potent Antiretroviral Therapy: Analysis of Immunophenotypic Marker Results of AACTG 5067

By D’Amico Ronald   Yang Yijun   Mildvan Donna   Evans Scott   Schnizlein-Bick Carol   Hafner Richard   Webb Nancy   Basar Michael   Zackin Robert   Jacobson Mark  

Journal of Clinical Immunology, Vol. 25, Iss. 2, 2005-03 ,pp. : 106-115

Springer Publishing Company

Access to resources Recommend Favorite